REPORT FORMAT
Marketed Drug Market Status Table
Note: Report links have been disabled for this sample screen.

SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS


Your search found 2 records. Click on a developer link to see more information.

Developer

Designation

Description

Approved/Filed Indications

BioAlliance Pharma
Affiliate(s):
Par Pharmaceutical
SpePharm (terminated 2/09)
Therabel Group
Other


Current as of: April 17, 2010
 

Generic Name: Miconazole
Brand Name: Loramyc (Europe, Miconazole Lauriad, Oravig (USA)
 

Loramyc comprises miconazole, an antifungal agent with broad-spectrum activity against various species of Candida, formulated with the Lauriad extended release tablet delivery platform (miconazole Lauriad bioadhesive buccal tablet).

Administration Route: PO  

• oropharyngeal candidiasis (OPC) in immunocompromized patients, particularly those with head and neck cancer treated with radiotherapy, and those infected with HIV
   

GlaxoSmithKline
Affiliate(s):
University of Florida Gainsville


Current as of: February 05, 2010
 

Generic Name: Topotecan
Brand Name: Hycamtin, Hycaptamine
Other Designation: NSC-609699, SK&F-104864  

Topotecan, a water-soluble camptothecin analog, is a topoisomerase I inhibitor.

Administration Route: intravenous (IV) • PO • intracerebral  

• ovarian cancer, metastatic, second or third line-IV
• small cell lung cancer (sclc), refractory, second line treatment-IV
• small cell lung cancer (sclc), relapsed, when retreatment with the first line regimen is not considered appropriate, IV
• cervical cancer, Stage IVb recurrent or persistent not amenable to curative treatment with surgery and/or radiation therapy, in combination with cisplatin-IV
• small cell lung cancer (sclc), relapsed-PO
 

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM